Table: begin end state 1 19 non-cytoplasmic 20 49 transmembrane 50 60 cytoplasmic 61 82 transmembrane 83 108 non-cytoplasmic 109 136 transmembrane 137 146 cytoplasmic 147 167 transmembrane 168 172 non-cytoplasmic 173 191 transmembrane 192 203 non-cytoplasmic 204 225 transmembrane 226 256 cytoplasmic 257 273 transmembrane 274 318 cytoplasmic 319 340 transmembrane 341 358 non-cytoplasmic 359 385 transmembrane 386 392 cytoplasmic 393 411 transmembrane 412 414 cytoplasmic 415 416 non-cytoplasmic 417 446 transmembrane 447 467 non-cytoplasmic 468 491 transmembrane 492 502 cytoplasmic
Input: >PfGW456L13_3733 VDILSSLAMGFSSALTPINLMWGFIGCLLGTAIGVLPGIGPALTVALLLPITAKVDPTGA LIMFAGIYYGAQFGGSTTSILLNTPGESSSMVTALEGNLMARNGRAGPALATAAIGSFVA GTIATVLLTLFAPVVARLALNFGPTEYFAILVLSFTTVSAVLGASMLRGFASLGVGLTIG LIGLDSTSGIARYTLGVPELVDGIEVVLVAVGLFAVGEALYSLLYQGESNEGRHRLTSLW MTRADWKRSVPAWLRGTLIGFPFGSIPAGGAEIPTFLSYSAERKLSKYPKEFSANKGEGA IEGVAGPEAANNASATGSLVPLLTLGIPTSATAAILLAAFQNYNLQPGPMLFETSADLVW TLVASLYIGNVILLVLNLPLVGLWVKLLQIPRPYLNAGILVFATIGVYGMRHSSFDLILM LAIGWGGVLMRRFDFPVAPVIVGMLLGPMAEKQLRNALSISQGDWTVFVTQPISAFFLAL TLLVLMVPYVLHKRGIKLHEDD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server